Quality in Care (QiC) Hepatitis C awards programme recognises, rewards and shares good practice in hepatitis C prevention, diagnosis & testing, treatment pathways and patient support throughout the UK.
The programme has the endorsement, support and active participation of a number of key stakeholders.
Gaining QiC recognition means an initiative has been highlighted by the NHS, patients and industry as improving patient outcomes and standards of care in hepatitis C.
Across all categories judges are looking for projects that have improved patient experience
- Demonstrate results showing quality
- Demonstrate results showing efficiency benefits
- Be scalable across organisations
- Show evidence of external review of the initiative
- Show evidence of support from users of the service
- Demonstrate patient/user involvement in the design of the project
- Demonstrate sustainability and transferability to other service areas.
The QiC Hepatitis C awards programme comprises a recognition event and subsequent dissemination opportunities for finalists to share good practice and demonstrate the benefits and adaptability of their initiatives to a wider healthcare audience.
Entries are invited from UK-based organisations: the NHS and other healthcare providers, industry and patient associations/charities.
award winning case studies
The QiC Hepatitis C programme is supported by the British HIV Association, HCV Action, Hep C Positive, Liver4Life, mPharma, The Hepatitis C Trust and Waverley Care.
What people think of QiC
"I am thrilled that QiC is now establishing itself as an essential forum sharing good practice, expertise and experience. In an era when localism rules and government strategies are only advisory, best practice sharing is the key method for driving improvements in services for patients."
Charles Gore – Chief Executive, The Hepatitis C Trust
"Liver4Life is delighted to support the QiC awards for hepatitis C. Recognising excellence in patient care is crucial to improving the patient journey - we are pleased that these awards offers an opportunity to showcase key initiatives for wider implementation."
Richard Hall and Sarah Matthews, Co-Founders of Liver4Life
"The major breakthroughs in HCV therapy leading to the ability to cure almost everyone, need to be matched by developments in delivery diagnosis, therapy and cure to patients. By recognising excellence and advances in these areas the QiC hepatitis awards are showcasing best practice in the NHS that should be replicated across the country."
John Dillon - Clinical Reader, Honorary Consultant Hepatologist & Gastroenterologist, Medical Research Institute, Ninewells Hospital, University of Dundee
"We are proud to support and be associated with QiC Hepatitis C. At this time of great advances in therapeutics in this area, it is important that innovative and quality care is showcased so that there is equity of care for all and that no-one is left behind."
Dr Sanjay Bhagani, Consultant Physician and honorary Senior Lecturer, Department of Infectious Diseases/HIV Medicine, Royal Free London Foundation Trust, Research Department of Infection, UCL
"Hep C Positive is delighted to support and endorse QiC's mission to
raise awareness of Hepatitis C and to help explore and share 'best practice' in
the field which will ultimately help all our patients progress with their
Phil Spalding, Co-founder of Hep C Positive